Skip to main content
Premium Trial:

Request an Annual Quote

DeltaDot, Partners Get $900K Grant for New Drug Development Tool

NEW YORK (GenomeWeb News) - DeltaDot and Integrated Technologies said today they have received a £465,000 ($900,000) grant from the South East England Development Agency to develop a new tool that will use protein folding structures to help speed drug development.
 
The system, called the Osprey Biomolecule Stability Analyzer, is a microfluidic instrument that uses DeltaDot's Label Free Intrinsic Imaging to characterize protein properties. The system is being developed to test drug candidates against protein structures and dynamics, the company said.
 
The company is targeting the market for biopharmaceutical quality assurance as the first application for Osprey. 
 

ITL director Greg Smith said that the technology is expected to “reduce drug selection times dramatically.”

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.